223
Views
35
CrossRef citations to date
0
Altmetric
Review

The role of mast cells in male infertility

, , , , &
Pages 627-634 | Published online: 10 Jan 2014

References

  • Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ. Mast cells in the promotion and limitation of chronic inflammation. Immunol. Rev.217, 304–328 (2007).
  • Hermo L, Lalli M. Monocytes and mast cells in the limiting membrane of human seminiferous tubules. Biol. Reprod.19(1), 92–100 (1978).
  • Behrendt H, Hilscher B, Passia D, Hofmann N, Hilscher W. The occurrence of mast cells in the human testis. Acta Anat.111, 14–16 (1981).
  • Maseki Y, Miyake K, Mitsuya H, Kitamura H, Yamada K. Mastocytosis occurring in the testes from patients with idiopathic male infertility. Fertil. Steril.36(6), 814–817 (1981).
  • Nistal M, Santamaria L, Paniagua R. Mast cells in the human testis and epididymis from birth to adulthood. Acta Anat. (Basel)119(3), 155–160 (1984).
  • Frungieri MB, Calandra RS, Lustig L et al. Number, distribution pattern, and identification of macrophages in the testes of infertile men. Fertil. Steril.78(2), 298–306 (2002).
  • Pejler G, Abrink M, Ringvall M, Wernersson S. Mast cell proteases. Adv. Immunol.95, 167–255 (2007).
  • Pejler G, Ronnberg E, Waern I, Wernersson S. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood115(24), 4981–4990 (2010).
  • Benoist C, Mathis D. Mast cells in autoimmune disease. Nature420(6917), 875–878 (2002).
  • Malaviya R, Georges A. Regulation of mast cell-mediated innate immunity during early response to bacterial infection. Clin. Rev. Allergy Immunol.22(2), 189–204 (2002).
  • Galli SJ, Tsai M. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur. J. Immunol.40(7), 1843–1851 (2010).
  • Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol.10(6), 440–452 (2010).
  • Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol. Rev.173, 131–140 (2000).
  • Metz M, Maurer M. Mast cells – key effector cells in immune responses. Trends Immunol.28(5), 234–241 (2007).
  • Abraham SN, Malaviya R. Mast cells in infection and immunity. Infect. Immun.65(9), 3501–3508 (1997).
  • Rodewald HR, Dessing M, Dvorak AM, Galli SJ. Identification of a committed precursor for the mast cell lineage. Science271(5250), 818–822 (1996).
  • Galli SJ, Hammel I. Mast cell and basophil development. Curr. Opin. Hematol.1(1), 33–39 (1994).
  • Abonia JP, Austen KF, Rollins BJ et al. Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood105(11), 4308–4313 (2005).
  • Hogan AD, Schwartz LB. Markers of mast cell degranulation. Methods13(1), 43–52 (1997).
  • Nakae S, Suto H, Berry GJ, Galli SJ. Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood109(9), 3640–3648 (2007).
  • Oliveira SH, Lukacs NW. Stem cell factor and IgE-stimulated murine mast cells produce chemokines (CCL2, CCL17, CCL22) and express chemokine receptors. Inflamm. Res.50(3), 168–174 (2001).
  • Moon TC, St Laurent CD, Morris KE et al. Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal. Immunol.3(2), 111–128 (2010).
  • Fijak M, Meinhardt A. The testis in immune privilege. Immunol. Rev.213, 66–81 (2006).
  • Damazo A, Paul-Clark M, Straus A, Takahashi H, Perretti M, Oliani S. Analysis of annexin 1 expression in rat trachea: study of the mast cell heterogeneity. Annexins1, 12–18 (2004).
  • De Jonge F, Van Nassauw L, Van Meir F, Miller HR, Van Marck E, Timmermans JP. Temporal distribution of distinct mast cell phenotypes during intestinal schistosomiasis in mice. Parasite Immunol.24(5), 225–231 (2002).
  • Kawakubo K, Akiba Y, Adelson D et al. Role of gastric mast cells in the regulation of central TRH analog-induced hyperemia in rats. Peptides26(9), 1580–1589 (2005).
  • Yamanaka K, Fujisawa M, Tanaka H, Okada H, Arakawa S, Kamidono S. Significance of human testicular mast cells and their subtypes in male infertility. Hum. Reprod.15(7), 1543–1547 (2000).
  • Enerback L. The differentiation and maturation of inflammatory cells involved in the allergic response: mast cells and basophils. Allergy52(1), 4–10 (1997).
  • Dohle GR, Colpi GM, Hargreave TB, Papp GK, Jungwirth A, Weidner W. EAU guidelines on male infertility. Eur. Urol.48(5), 703–711 (2005).
  • Tuttelmann F, Nieschlag E. Classification of andrological disorders. In: Andrology: Male Reproductive Health and Dysfunction. Nieschlag E, Behre HM, Nieschlag S (Eds). Springer, NY, USA, 90–96 (2009).
  • Schuppe HC, Meinhardt A, Allam JP, Bergmann M, Weidner W, Haidl G. Chronic orchitis: a neglected cause of male infertility? Andrologia40(2), 84–91 (2008).
  • Haidl G, Allam JP, Schuppe HC. Chronic epididymitis: impact on semen parameters and therapeutic options. Andrologia40(2), 92–96 (2008).
  • Schuppe HC, Meinhardt A. Immune privilege and inflammation of the testis. Chem. Immunol. Allergy88, 1–14 (2005).
  • Hedger MP. Testicular leukocytes: what are they doing? Rev. Reprod.2(1), 38–47 (1997).
  • Weidner W, Krause W, Ludwig M. Relevance of male accessory gland infection for subsequent fertility with special focus on prostatitis. Hum. Reprod. Update5(5), 421–432 (1999).
  • Doncel GF, Di Paola JA, Lustig L. Sequential study of the histopathology and cellular and humoral immune response during the development of an autoimmune orchitis in Wistar rats. Am. J. Reprod. Immunol.20(2), 44–51 (1989).
  • Suescun MO, Rival C, Theas MS, Calandra RS, Lustig L. Involvement of tumor necrosis factor-α in the pathogenesis of autoimmune orchitis in rats. Biol. Reprod.68(6), 2114–2121 (2003).
  • Rival C, Lustig L, Iosub R et al. Identification of a dendritic cell population in normal testis and in chronically inflamed testis of rats with autoimmune orchitis. Cell Tissue Res.324(2), 311–318 (2006).
  • Anton F, Morales C, Aguilar R, Bellido C, Aguilar E, Gaytan F. A comparative study of mast cells and eosinophil leukocytes in the mammalian testis. Zentralbl. Veterinarmed. A.45(4), 209–218 (1998).
  • Meineke V, Frungieri MB, Jessberger B, Vogt H, Mayerhofer A. Human testicular mast cells contain tryptase: increased mast cell number and altered distribution in the testes of infertile men. Fertil. Steril.74(2), 239–244 (2000).
  • Hussein MR, Abou-Deif ES, Bedaiwy MA et al. Phenotypic characterization of the immune and mast cell infiltrates in the human testis shows normal and abnormal spermatogenesis. Fertil. Steril.83(5), 1447–1453 (2005).
  • Schuppe HC, Neumann N, Schock-Skasa G, Scheffzyk A, Schill WB. Mast cells in testicular inflammatory reactions: conductors, players, or innocent bystanders? Andrologia34, 152 (2002) (Abstract).
  • Iosub R, Klug J, Fijak M et al. Development of testicular inflammation in the rat involves activation of proteinase-activated receptor-2. J. Pathol.208(5), 686–698 (2006).
  • Walsh LJ. Mast cells and oral inflammation. Crit. Rev. Oral Biol. Med.14(3), 188–198 (2003).
  • Jimenez-Trejo F, Tapia-Rodriguez M, Queiroz DB et al. Serotonin concentration, synthesis, cell origin, and targets in the rat caput epididymis during sexual maturation and variations associated with adult mating status: morphological and biochemical studies. J. Androl.28(1), 136–149 (2007).
  • Apa DD, Cayan S, Polat A, Akbay E. Mast cells and fibrosis on testicular biopsies in male infertility. Arch. Androl.48(5), 337–344 (2002).
  • Hofmann N, Klasa M, Behrendt H et al. Appearance of mast cells in human testis with sertoli cell only syndrome. In: Fortschritte der Andrologie. Schirren C (Ed.). Grosse, Berlin, Germany, 122–129 (1983).
  • Bergmann M. Evaluation of testicular biopsy samples from the clinical perspective. In: Andrology for the Clinician. Schill WB, Comhaire FH, Hargreave TB (Eds). Springer, Heidelberg, Germany, 454–461 (2006).
  • McLachlan RI, Rajpert-De Meyts E, Hoei-Hansen CE, de Kretser DM, Skakkebaek NE. Histological evaluation of the human testis – approaches to optimizing the clinical value of the assessment: mini review. Hum. Reprod.22(1), 2–16 (2007).
  • Jezek D, Banek L, Hittmair A, Pezerovic-Panijan R, Goluza T, Schulze W. Mast cells in testicular biopsies of infertile men with ‘mixed atrophy’ of seminiferous tubules. Andrologia31(4), 203–210 (1999).
  • Roaiah MM, Khatab H, Mostafa T. Mast cells in testicular biopsies of azoospermic men. Andrologia39(5), 185–189 (2007).
  • Haidl G. Which efforts towards conservative treatment of male infertility will be successful? Mast cell blockers. Andrologia31(5), 299–300 (1999).
  • Nagai T, Takaba H, Miyake K, Hirabayashi Y, Yamada K. Testicular mast cell heterogeneity in idiopathic male infertility. Fertil. Steril.57(6), 1331–1336 (1992).
  • Weidinger S, Mayerhofer A, Kunz L et al. Tryptase inhibits motility of human spermatozoa mainly by activation of the mitogen-activated protein kinase pathway. Hum. Reprod.20(2), 456–461 (2005).
  • Steinhoff M, Vergnolle N, Young SH et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med.6(2), 151–158 (2000).
  • Frungieri MB, Weidinger S, Meineke V, Kohn FM, Mayerhofer A. Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARγ: Possible relevance to human fibrotic disorders. Proc. Natl Acad. Sci. USA99(23), 15072–15077 (2002).
  • Albrecht M, Frungieri MB, Gonzalez-Calvar S, Meineke V, Kohn FM, Mayerhofer A. Evidence for a histaminergic system in the human testis. Fertil. Steril.83(4), 1060–1063 (2005).
  • Levi-Schaffer F, Piliponsky AM. Tryptase, a novel link between allergic inflammation and fibrosis. Trends Immunol.24(4), 158–161 (2003).
  • Hedger MP, Meinhardt A. Cytokines and the immune-testicular axis. J. Reprod. Immunol.58(1), 1–26 (2003).
  • Smith TJ, Parikh SJ. HMC-1 mast cells activate human orbital fibroblasts in coculture: evidence for up-regulation of prostaglandin E2 and hyaluronan synthesis. Endocrinology140(8), 3518–3525 (1999).
  • Duan YG, Yu CF, Novak N et al. Immunodeviation towards a Th17 immune response associated with testicular damage in azoospermic men. Int. J. Androl. DOI:10.1111/j.1365–2605.2010.01137.x. (2011) (Epub ahead of print).
  • Stephan JP, Syed V, Jegou B. Regulation of sertoli cell IL-1 and IL-6 production in vitro. Mol. Cell Endocrinol.134(2), 109–118 (1997).
  • Rival C, Theas MS, Suescun MO et al. Functional and phenotypic characteristics of testicular macrophages in experimental autoimmune orchitis. J. Pathol.215(2), 108–117 (2008).
  • Hedger MP, Hales DB. Immunophysiology of the male reproductive tract. In: Knobil and Neill’s Physiology of Reproduction. Neill JD (Ed.). Elsevier Inc., Amsterdam, The Netherlands, 1195–1286 (2006).
  • Gaytan F, Carrera G, Pinilla L, Aguilar R, Bellido C. Mast cells in the testis, epididymis and accessory glands of the rat: effects of neonatal steroid treatment. J. Androl.10(5), 351–358 (1989).
  • Theoharides TC, Flaris N, Cronin CT, Ucci A, Meares E. Mast cell activation in sterile bladder and prostate inflammation. Int. Arch. Allergy Appl. Immunol.92(3), 281–286 (1990).
  • Gupta RK. Mast cell variations in prostate and urinary bladder. Arch. Pathol.89(4), 302–305 (1970).
  • Keith IM, Jin J, Neal D Jr, Teunissen BD, Moon TD. Cell relationship in a Wistar rat model of spontaneous prostatitis. J. Urol.166(1), 323–328 (2001).
  • Bankl HC, Samorapoompichit P, Pikula B et al. Characterization of human prostate mast cells and their increase in periprostatic vein thrombosis. Am. J. Clin. Pathol.116(1), 97–106 (2001).
  • Pontari MA, Ruggieri MR. Mechanisms in prostatitis/chronic pelvic pain syndrome. J. Urol.179(Suppl. 5), S61–S67 (2008).
  • Ellem SJ, Wang H, Poutanen M, Risbridger GP. Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy. Am. J. Pathol.175(3), 1187–1199 (2009).
  • Fibbi B, Penna G, Morelli A, Adorini L, Maggi M. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int. J. Androl.33(3), 475–488 (2010).
  • Mendes LO, Amorim JP, Teixeira GR et al. Mast cells and ethanol consumption: interactions in the prostate, epididymis and testis of UChB rats. Am. J. Reprod. Immunol.66(3), 170–178 (2011).
  • El-Karaksy A, Mostafa T, Shaeer OK, Bahgat DR, Samir N. Seminal mast cells in infertile asthenozoospermic males. Andrologia39(6), 244–247 (2007).
  • Allam JP, Langer M, Fathy A et al. Mast cells in the seminal plasma of infertile men as detected by flow cytometry. Andrologia41(1), 1–6 (2009).
  • Weidinger S, Mayerhofer A, Frungieri MB, Meineke V, Ring J, Kohn FM. Mast cell-sperm interaction: evidence for tryptase and proteinase-activated receptors in the regulation of sperm motility. Hum. Reprod.18(12), 2519–2524 (2003).
  • Schill WB, Schneider J, Ring J. The use of ketotifen, a mast cell blocker, for treatment of oligo- and asthenozoospermia. Andrologia18(6), 570–573 (1986).
  • Yamamoto M, Hibi H, Miyake K. Appearance of spermatozoon after administration of mast cell blocker to a patient with azoospermia. Hinyokika Kiyo40(6), 541–543 (1994).
  • Yamamoto M, Hibi H, Miyake K. New treatment of idiopathic severe oligozoospermia with mast cell blocker: results of a single-blind study. Fertil. Steril.64(6), 1221–1223 (1995).
  • Hibi H, Kato K, Mitsui K et al. The treatment with tranilast, a mast cell blocker, for idiopathic oligozoospermia. Arch. Androl.47(2), 107–111 (2001).
  • Matsuki S, Sasagawa I, Suzuki Y et al. The use of ebastine, a mast cell blocker, for treatment of oligozoospermia. Arch. Androl.44(2), 129–132 (2000).
  • Cayan S, Apa DD, Akbay E. Effect of fexofenadine, a mast cell blocker, in infertile men with significantly increased testicular mast cells. Asian J. Androl.4(4), 291–294 (2002).
  • Oliva A, Multigner L. Ketotifen improves sperm motility and sperm morphology in male patients with leukocytospermia and unexplained infertility. Fertil. Steril.85(1), 240–243 (2006).
  • Azadi L, Abbasi H, Deemeh MR et al. Zaditen (Ketotifen), as mast cell blocker, improves sperm quality, chromatin integrity and pregnancy rate after varicocelectomy. Int. J. Androl. DOI:10.1111/j.1365–2605.2010.0111-2.x. (2010) (Epub ahead of print).
  • Ma K, Mallidis C, Bhasin S. The role of Y chromosone deletions in male infertility. Eur. J. Endocrinol.142(5), 418–430 (2000).
  • Clarnette T, Hutson J. Congential testicular maldescent. Br. J. Urol.77(4), 619–620 (1996).
  • Boekelheide K. Mechanisms of toxic damage to spermatogenesis. J. Natl Cancer Inst. Monogr.34(3), 6–8 (2005).
  • Dokmeci D. Testicular torsion, oxidative stress and the role of anti-oxidant therapy. Folia. Med. (Plovdiv)48(3–4), 16–21 (2006).
  • Romeo C, Santoro G. Varicocele and infertility: why a prevention? J. Endocrinol. Invest.32(6), 559–561 (2009).
  • Matsumiya K, Namiki M, Takahara S et al. Clinical study of azoospermia. Int. J. Androl.17(3), 140–142 (1994).
  • Winter C, Albers P. Testicular germ cell tumors: pathogenesis, diagnosis and treatment. Nat. Rev. Endocrinol.7(1), 43–53 (2011).
  • Palit V, Eardley I. An update on new oral PDE5 inhibitors for the treatment of erectile dysfunction. Nat. Rev. Urol.7(11), 603–609 (2010).
  • Wang MH, Baskin LS. Endocrine disruptors, genital development, and hypospadias. J. Androl.29(5), 499–505 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.